Aplicativos móveis para pacientes pós transplante de medula óssea: revisão integrativa
DOI:
10.24276/rrecien2022.12.38.206-217Palavras-chave:
Aplicativos Móveis, Transplante de Medula Óssea, Transplante de Células-Tronco Hematopoéticas, RevisãoResumo
Revisão integrativa da literatura com objetivo de analisar produções científicas sobre uso de aplicativos móveis na área de Transplante de Medula Óssea. Busca realizada com os descritores Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Mobile Applications, nas bases de dados SCOPUS, Pubmed e LILACS, em abril de 2021. Encontrou-se 46 publicações, destas 11 foram incluídas na revisão e classificadas por: base de dados, título, autores, país de origem, periódico e ano de publicação, delineamento, grau de recomendação, nível de evidência, tema, objetivo e resultados. Dos artigos 5 (45,45%), publicados em 2020, 9 (81,81%) desenvolvidos nos Estados Unidos, 10 (90,90%), possuem grau de recomendação B e 5 (45,45%) apresentam nível de evidência 2c. Conclui-se o êxito dos aplicativos móveis como produto de tecnologia em saúde, porém é necessário investimento em mais estudos buscando disseminar a tecnologia em saúde e melhora nos níveis de evidência e qualidade das publicações na área.
Descritores: Aplicativos Móveis, Transplante de Medula Óssea, Transplante de Células-Tronco Hematopoéticas, Revisão.
Mobile apps for post bone marrow transplant patients: integrative review
Abstract: Integrative literature review aiming to analyze scientific productions on the use of mobile applications in the area of Bone Marrow Transplantation. Search performed with the descriptors Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Mobile Applications, in SCOPUS, Pubmed and LILACS databases, in April 2021. 46 publications were found, of which 11 were included in the review and classified by: database data, title, authors, country of origin, journal and year of publication, design, degree of recommendation, level of evidence, theme, objective and results. Of the 5 articles (45.45%) published in 2020, 9 (81.81%) developed in the United States, 10 (90.90%) have a degree of recommendation B and 5 (45.45%) have a level of evidence 2c. The success of mobile applications as a health technology product is concluded, but investment in more studies is needed to disseminate health technology and improve the levels of evidence and quality of publications in the area.
Descriptors: Mobile Applications, Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation, Review.
Aplicaciones móviles para pacientes post trasplante de médula ósea: revisión integradora
Resumen: Revisión integrativa de la literatura con el objetivo de analizar las producciones científicas sobre el uso de aplicaciones móviles en el área del Trasplante de Médula Ósea. Búsqueda realizada con los descriptores Bone Marrow Transplantation, Hematopoytic Stem Cell Transplantation, Mobile Applications, en las bases de datos SCOPUS, Pubmed y LILACS, en abril de 2021. Se encontraron 46 publicaciones, de las cuales 11 fueron incluidas en la revisión y clasificadas por: datos de la base de datos, título, autores, país de origen, revista y año de publicación, diseño, grado de recomendación, nivel de evidencia, tema, objetivo y resultados. De los 5 artículos (45,45%) publicados en 2020, 9 (81,81%) desarrollados en Estados Unidos, 10 (90,90%) tienen un grado de recomendación B y 5 (45,45%) tienen un nivel de evidencia 2c. Se concluye el éxito de las aplicaciones móviles como producto de tecnología sanitaria, pero se necesita invertir en más estudios para difundir la tecnología sanitaria y mejorar los niveles de evidencia y calidad de las publicaciones en el área.
Descriptores: Aplicaciones Móviles, Trasplante de Médula Ósea, Trasplante de Células Madre Hematopoyéticas, Revisión.
Downloads
Referências
Stecher SS, Stemmler HJ, Tischer J, et al. Der knochenmarktransplantierte Patient auf der Intensivstation. Med Klin Intensivmed Notfmed. 2021; 116:111-120.
Beres AJ, Drobyski WR. The role of regulatoryT cells in the biology of graft versus host disease. Front Immunol. 2013; 4:163.
Associação Brasileira de Transplante de Orgãos. Registro Brasileiro de Transplantes (RBT): Dimensionamento dos transplantes no Brasil em cada estado (2012-2019). São Paulo: ABTO. 2019; 25(4).
Bevans M, El-Jawahri A, Tierney DK, et al. National institutes of health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017; 23(4): 538-551.
Kong SG, Jeong S, Lee S, et al. Early transplantation-related mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia. BMC Cancer 21. 2021; 177.
Vere Hunt I, Kilgour JM, Danby R, et al. “Is this the GVHD?” A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service. Health Qual Life Outcomes. 2021; 19(11).
Barros ENL, Farias PS, Lourenço AKR, Pontes AN, Alves Junior MM, Silva JM. O uso das tecnologias auxiliadoras à saúde: desafios e benefícios. Div Journ. 2021; 6(1):698-12.
Galvão TF, Pansani TSA. Principais itens para relatar Revisões sistemáticas e meta-análises: a recomendação PRISMA Epidemiol Serv Saúde. 2015; 24(2):335-342.
Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010; 8(1):102-6.
Santos CMC, Pimenta CAM, Nobre MRCuce. The PICO strategy for the research question construction and evidence search. Rev Latino Am Enferm. 2007; 15(3):508-511.
Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009; 6(7):e1000097.
Phillips B, Ball C, Sackett D, Sackett D, Badenoch D, Straus S, et al.; Oxford Centre for Evidence-based Medicine. Levels of evidence. Oxford: CEBM. 2009. Disponível em: <https://www.cebm.net/2009/06/oxford-centre-evidence-basedmedicine-levels-evidence-march-2009/>.
Gupta V, Raj M, Hoodin F, Yahng L, Braun T, Choi SW. Electronic Health Record Portal Use by Family Caregivers of Patients Undergoing Hematopoietic Cell Transplantation: United States National Survey Study. JMIR Cancer. 2021; 7(1):e26509.
Preussler JM, Denzen EM, Majhail, NS, et al. Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools. Support Care Cancer. 2020; 28:2805–2816.
Duettmann W, Naik MG, Zukunft B, Osmonodja B, Bachmann F, Choi M, et al. eHealth in transplantation. Transplant International. 2021; 34:16-26.
Vaughn J, Shah N, Jonassaint J, Harris N, Docherty S, Shaw R. User-Centered App Design for Acutely Ill Children and Adolescents. Journal of Pediatric Oncology Nursing. 2020; 37(6):359-367.
Lawitschka A, Buehrer S, Bauer D, Peters K, Silbernagl M, Zubarovskaya N, et al. A Web-Based Mobile App (INTERACCT App) for Adolescents Undergoing Cancer and Hematopoietic Stem Cell Transplantation Aftercare to Improve the Quality of Medical Information for Clinicians: Observational Study. JMIR Mhealth Uhealth. 2020; 8(6):e1878.
Kedroske J, Koblick S, Chaar D, Mazzoli A, O'Brien M, Yahng L, et al. Development of a National Caregiver Health Survey for Hematopoietic Stem Cell Transplant: Qualitative Study of Cognitive Interviews and Verbal Probing. JMIR Form Res. 2020; 4(1):e17077.
Racioppi A, Dalton T, Ramalingam S, Romero K, Ren Y, Bohannon L, et al. Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients. Transplantation and Cellular Therapy. 2021; 27(2):181-189.
Chaar D, Shin JY, Mazzoli A, Vue R, Kedroske J, Chappell G, et al. A Mobile Health App (Roadmap 2.0) for Patients Undergoing Hematopoietic Stem Cell Transplant: Qualitative Study on Family Caregivers' Perspectives and Design Considerations. JMIR Mhealth Uhealth. 2019; 7(10):e15775.
Vaughn J, Jonassaint J, Summers-Goeckerman E, Shaw RJ, Shah N. Customization of the TRU-PBMT App (Technology Recordings to better Understand Pediatric Blood and Marrow Transplant). Journal of Pediatric Nursing. 2018; 42:86-91.
Wesley KM, Fizur PJ. A review of mobile applications to help adolescent and young adult cancer patients. Adolescent Health, Medicine and Therapeutics. 2015; 6:141-148.
Rodgers CC, Krance, R, Street RL, Hockenberry MJ. Feasibility of a Symptom Management Intervention for Adolescents Recovering From a Hematopoietic Stem Cell Transplant. Cancer Nursing. 2013; 5(36):394-399.
Oliveira HHN, Carvalho ZV. Estratégias de desenvolvimento socioeconômico: ecossistemas de inovação para implantação de smart cities - estudos de casos no Estados Unidos, China E Suécia. In 8th International Symposium on Technological Innovation. Universidade Federal de Sergipe. 2017; 8(1):224-234.
Riley WT, Oh A, Aklin WM, Sherrill JT, Wolff-Hughes DL, Diana A, et al. Commentary: Pediatric digital health supported by the National Institutes of Health. Journal of Pediatric Psychology. 2019; 44(3):263-268.
Publicado
- Visualizações 0
- pdf downloads: 0
